Point72 Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.75M Buy
66,400
+42,600
+179% +$4.08M 0.01% 1608
2025
Q4
$2.29M Sell
23,800
-92,600
-80% -$8.99M ﹤0.01% 2392
2025
Q3
$11.1M Buy
116,400
+107,800
+1,253% +$9.91M 0.02% 754
2025
Q2
$750K Sell
8,600
-2,900
-25% -$246K ﹤0.01% 1651
2025
Q1
$1.03M Sell
11,500
-37,900
-77% -$3.39M ﹤0.01% 1436
2024
Q4
$3.95M Sell
49,400
-2,800
-5% -$242K 0.01% 1027
2024
Q3
$4.7M Sell
52,200
-38,700
-43% -$3.26M 0.01% 898
2024
Q2
$7.15M Buy
90,900
+48,700
+115% +$3.99M 0.02% 733
2024
Q1
$3.68M Buy
42,200
+41,400
+5,175% +$3.53M 0.01% 1069
2023
Q4
$65.9K Buy
+800
New +$61K ﹤0.01% 1985
2023
Q2
Sell
-3,800
Closed -$306K 2529
2023
Q1
$306K Buy
+3,800
New +$310K ﹤0.01% 1352
2022
Q3
Sell
-30,300
Closed -$2.72M 1605
2022
Q2
$2.72M Buy
+30,300
New +$3.07M 0.01% 867

Other funds holding MDT

Point72 Asset Management's MDT Position: Q3 2025 in Review

Point72 Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 320,665 shares — an estimated $29.5M sold.

Point72 Asset Management first reported a position in MDT in Q2 2014 and held it in 33 quarters. The position peaked at $128M in Q4 2017. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Point72 Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Point72 Asset Management sold 320,665 Medtronic shares in Q3 2025, an estimated $29.5M.
  • Point72 Asset Management first reported a position in Medtronic in Q2 2014 and held it in 33 quarters.
  • Point72 Asset Management's Medtronic position peaked at $128M in Q4 2017.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.